Comparison of the effects of losartan, enalapril and their combination in the prevention of left ventricular remodeling after acute myocardial infarction in the rat

Chinese Medical Sciences Journal

Volumn 17, Issue 4, 2002, Pages 236-241

  Yang, Yuejin ^a   Zhang, Pei ^a   Ruan, Yingmao ^a   Song, Laifeng ^a   Xu, Xinglin ^a   Li, Yongli ^a   Zhou, Yanwen ^a   Tian, Yi ^a   Xu, Yishu ^a   Chen, Zaijia ^a  

^a NONE

Author keywords

Enalapril; Left ventricular remodeling; Losartan; Myocardial infarction

Indexed keywords

ENALAPRIL; LOSARTAN;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DIASTOLE; DRUG EFFECT; FEMALE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART VENTRICLE REMODELING; HEART WEIGHT; HEMODYNAMICS; NONHUMAN; RANDOMIZATION; RAT; RAT STRAIN; SYSTOLE;

EID: 12244302495     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Blaufarb IS, Sonnenblick EH. The renin-angiotensin system in left ventricular remodeling. Am J Cardiol 1996; 77: 8c-16c.
2. Olivetti G, Capasso JM, Meggs LG, et al. Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res 1991; 68: 856-69.
3. Pfeffer JM, Pfeffer MA, Braunwald E, et al. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 1985; 57: 84-95.
4. Sladek T, Sladkova J, Kolar F, et al. The effect of AT1 receptor antagonist on chronic cardiac response to coronary artery ligation in rats. Cardiovasc Res 1996; 31: 568-76.
5. Richer C, Fornes P, Cazaubon C, et al. Effects of long-term angiotensin II AT1 receptor blockade on survival, hemodynamics and cardiac remodeling in chronic heart failure in rats. Cardiovasc Res 1999; 41: 100-8.
6. Carr RD, Killingback PG, Mitchell PD, et al. Comparative inhibitory effects of FLP 63547 and enalapril on rat tissue converting enzyme. Br J Pharmacol 1989; 89: 658P.
7. Hamroff G, Blanfarb I, Mancini D, et al. Angiotensin II receptor blockade further reduces afterload safely in patients maximally treated with angiotensin converting enzyme inhibitor for heart failure. J Cardiovasc Pharmacol 1997; 30: 533-6.
8. Azizi M, Chatellier G, Guyene TT. Additive effects of combined angiotensin-converting enzgme inhibition and angiotensin II antagonist on blood pressure and renin release in sodium-depleted normotensives. Circulation 1995; 92: 825-34.
9. McDonald KM, Garr M, Carlyle PF, et al. Relative effects of adrenoceptor blockade, ACEI therapy, and angiotensin II subtype 1 receptor blockade on ventricular remodeling in the dog. Circulation 1994; 90: 3034-46.
10. Yamagishi H, Kim S, Nishikimi T, et al. Contribution of cardial renin-angiotensin system to ventricular remodeling in myocardial infarcted rats. J Mol Cell Cardiol 1993; 25: 1369-80.
11. Capasso JM. Angiotensin antagonists in models of heart failure. In: Saavedra Jm, Timmermans. PBMWM, editors. Angiotensin receptors. New York: Plenum Press; 1994. p. 255-86.